Skip to main content

Home/ Health affairs/ Group items tagged Benefits-of-Tirzepatide-for-obesity

Rss Feed Group items tagged

pharmacybiz

Mounjaro: New Diabetes Medicine Approved for Weight Loss - 0 views

  •  
    A diabetes medicine, Mounjaro, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat overweight patients. The weight loss medication originally developed for Type 2 diabetes is now accessible to individuals aged 18 and over who are dealing with obesity and weight-related health issues. The active ingredient, tirzepatide, works by making the patient feel fuller and reducing food cravings. The injection helps individuals lose 20 per cent of their body weight, and are advised to follow a reduced-calorie diet and increase physical activity simultaneously. Although it is not authorised to use on the NHS as yet but future approvals can be predicted.
1 - 1 of 1
Showing 20 items per page